Humanities
Skip to main content Skip to main navigation menu Skip to site footer
  • Register
  • Login
  • Menu
  • Home
  • Current
  • Archives
  • Announcements
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Register
  • Login

Journal of Education, Health and Sport

Dynapenia syndrome in geriatrics – clinical characteristics, distinction from sarcopenia, and contemporary therapeutic approaches
  • Home
  • /
  • Dynapenia syndrome in geriatrics – clinical characteristics, distinction from sarcopenia, and contemporary therapeutic approaches
  1. Home /
  2. Archives /
  3. Vol. 88 (2026) /
  4. Health Sciences

Dynapenia syndrome in geriatrics – clinical characteristics, distinction from sarcopenia, and contemporary therapeutic approaches

Authors

  • Paulina Malon Nicolaus Copernicus University in Toruń, Collegium Medicum, Bydgoszcz https://orcid.org/0009-0008-9311-001X
  • Karol Śliwa University of Warmia and Mazury in Olsztyn, Collegium Medcium, ul. Oczapowskiego 2, 10-719 Olsztyn, Poland https://orcid.org/0009-0006-4181-9778
  • Anita Pieńkowska Independent Physician, Białystok, Poland https://orcid.org/0009-0008-9903-007X
  • Aleksandra Trojańska University Clinical Hospital in Poznań, Przybyszewskiego 49, 60-355 Poznań, Poland https://orcid.org/0009-0005-9659-875X
  • Nel Geworkian University Clinical Hospital in Poznań, Przybyszewskiego 49, 60-355 Poznań, Poland; https://orcid.org/0009-0008-2248-6052
  • Natalia Hariasz 4th Military Clinical Hospital in Wroclaw, Rudolfa Weigla 5, 50-981 Wrocław https://orcid.org/0009-0000-5397-0324
  • Martyna Pietz University Clinical Hospital in Poznań, Przybyszewskiego 49, 60-355 Poznań, Poland; https://orcid.org/0009-0003-7628-9517
  • Anita Szymańska Independent Physician, Poznań, Poland https://orcid.org/0009-0005-9762-3347

DOI:

https://doi.org/10.12775/JEHS.2026.88.68065

Keywords

dynapenia, muscle aging, functional capacity in older adults, resistance training, supplementation, protein, vitamin D, fall prevention

Abstract

Introduction

Dynapenia is an age-related loss of muscle strength despite preserved muscle mass, leading to functional decline, loss of independence, falls, and higher mortality. Its development is influenced by neuromuscular, endocrine, and metabolic changes, compounded by chronic inflammation, low activity, and inadequate nutrition.

Results 

Resistance training is the most effective strategy to mitigate strength loss, enhancing neuromuscular function and physical performance. Aerobic exercise improves endurance and mobility. Adequate protein intake (1.0–1.2 g/kg) and supplementation with vitamin D, creatine, leucine, and omega-3 fatty acids support training adaptations. Early detection via handgrip strength allows timely interventions.

Discussion 

Combining targeted exercise with optimal nutrition and supplementation maintains strength and independence in older adults. Interventions should be individualized based on health and functional status. Emerging molecular and gene-based therapies are experimental but may complement lifestyle approaches.

Conclusion 

Dynapenia is not inevitable with aging. Early recognition, regular training, and proper nutrition can slow strength loss, reduce fall risk, and improve well-being.

Materials and methods

A review of scientific articles from PubMed, Google Scholar, and Dove Press Medical focused on dynapenia, muscle aging, and physical and nutritional interventions in older adults.

References

[1] Clark BC, Manini TM. What is dynapenia? Nutrition. 2012 May;28(5):495-503. doi: 10.1016/j.nut.2011.12.002.

[2] Jung H, Tanaka S, Kataoka S, Tanaka R. Association of sarcopenia, pre-sarcopenia, and dynapenia with the onset and progression of locomotive syndrome in Japanese older adults: a cross-sectional study. J Physiol Anthropol. 2023 Aug 3;42(1):16. doi: 10.1186/s40101-023-00334-3.

[3] Mori H, Kuroda A, Matsuhisa M. Clinical impact of sarcopenia and dynapenia on diabetes. Diabetol Int. 2019 Jun 19;10(3):183-187. doi: 10.1007/s13340-019-00400-1.

[4] Huang CY, Hwang AC, Liu LK, Lee WJ, Chen LY, Peng LN, Lin MH, Chen LK. Association of Dynapenia, Sarcopenia, and Cognitive Impairment Among Community-Dwelling Older Taiwanese. Rejuvenation Res. 2016 Feb;19(1):71-8. doi: 10.1089/rej.2015.1710.

[5] Rechinelli AB, Marques IL, de Morais Viana ECR, da Silva Oliveira I, de Souza VF, Petarli GB, Rocha JLM, Guandalini VR. Presence of dynapenia and association with anthropometric variables in cancer patients. BMC Cancer. 2020 Oct 19;20(1):1010. doi: 10.1186/s12885-020-07519-4.

[6] Law TD, Clark LA, Clark BC. Resistance exercise to prevent and manage sarcopenia and dynapenia. Annu Rev Gerontol Geriatr 2016;36:205–28. DOI:10.1093/ageing/afac003

[7] Treuil M, Mahmutovic M, Di Patrizio P, Nguyen-Thi PL, Quilliot D. Assessment of dynapenia and undernutrition in primary care, a systematic screening study in community medicine. Clin Nutr ESPEN 2023;57:561–8. doi: 10.1016/j.clnesp.2023.08.003.

[8] Sivritepe R. The relationship between dynapenia and vitamin D level in geriatric women with type 2 diabetes mellitus. North Clin Istanb 2022;9:64–73. doi: 10.14744/nci.2021.28009.

[9] Tessier AJ, Chevalier S. An update on protein, leucine, omega-3 fatty acids, and vitamin D in the prevention and treatment of sarcopenia and functional decline. Nutrients 2018;10:1099. doi: 10.3390/nu10081099.

[10] Manini TM, Clark BC. Dynapenia and aging: an update. J Gerontol A Biol Sci Med Sci. 2012 Jan;67(1):28-40. doi: 10.1093/gerona/glr010.

[11] Sivritepe R, Siyer OK, Tiril SM, Basat SU. Do we know about dynapenia? North Clin Istanb. 2024 Nov 22;11(6):593-599. doi: 10.14744/nci.2024.48642.

[12] Jung H, Tanaka S, Tanaka R. Body Composition Characteristics of Community-Dwelling Older Adults With Dynapenia or Sarcopenia. Front Nutr. 2022 Apr 25;9:827114. doi: 10.3389/fnut.2022.827114. Erratum in: Front Nutr. 2022 Dec 20;9:1107965. doi: 10.3389/fnut.2022.1107965.

[13] Nilwik R, Snijders T, Leenders M, Groen BB, van Kranenburg J, Verdijk LB, et al. The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size. Exp Gerontol 2013;48:492–8. doi: 10.1016/j.exger.2013.02.012.

[14] Gungor O, Ulu S, Hasbal NB, Anker SD, Kalantar-Zadeh K. Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do? J Cachexia Sarcopenia Muscle 2021;12:1380–92. doi: 10.1002/jcsm.12839.

[15] Gupta P, Kumar S. Sarcopenia and endocrine ageing: are they related? Cureus 2022;14:e28787. doi: 10.7759/cureus.28787.

[16] Ribeiro JC, Duarte JG, Gomes GAO, Costa-Guarisco LP, de Jesus ITM, Nascimento CMC, et al. Associations between inflammatory markers and muscle strength in older adults according to the presence or absence of obesity. Exp Gerontol 2021;151:111409. doi: 10.1016/j.exger.2021.111409.

[17] Diaz-Morales N, Rovira-Llopis S, Escribano-Lopez I, Bañuls C, Lopez-Domenech S, Falcón R, et al. Role of oxidative stress and mitochondrial dysfunction in skeletal muscle in type 2 diabetic patients. Curr Pharm Des 2016;22:2650–6. doi: 10.2174/1381612822666160217142949.

[18] Rezuş E, Burlui A, Cardoneanu A, Rezuş C, Codreanu C, Pârvu M, et al. Inactivity and skeletal muscle metabolism: a vicious cycle in old age. Int J Mol Sci 202;21:592. doi: 10.3390/ijms21020592.

[19] Bohannon RW. Grip strength: an indispensable biomarker for older adults. Clin Interv Aging 2019;14:1681–91. doi: 10.2147/CIA.S194543.

[20] Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991;39:142– 8. doi: 10.1111/j.1532-5415.1991.tb01616.x.

[21] Treacy D, Hassett L. The short physical performance battery. J Physiother 2018;64:61. doi: 10.1016/j.jphys.2017.04.002.

[22] Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39:412–23. doi: 10.1093/ageing/afq034.

[23] DeVita MV, Stall SH. Dual-energy X-ray absorptiometry: a review. J Ren Nutr 1999;9:178–81. doi: 10.1016/s1051-2276(99)90030-4.

[24] Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019 Jun 29;393(10191):2636-2646. doi: 10.1016/S0140-6736(19)31138-9. Epub 2019 Jun 3. Erratum in: Lancet. 2019 Jun 29;393(10191):2590. doi: 10.1016/S0140-6736(19)31465-5.

[25] Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169. Erratum in: Age Ageing. 2019 Jul 1;48(4):601. doi: 10.1093/ageing/afz046.

[26] Yoo, K., Park, Y.S. & Kim, H.J. Handgrip strength, dynapenia, and health-related quality of life in older Korean adults. BMC Geriatr 25, 627 (2025). doi: 10.1186/s12877-025-06218-8.

[27] Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, Kojima T, Kuzuya M, Lee JSW, Lee SY, Lee WJ, Lee Y, Liang CK, Lim JY, Lim WS, Peng LN, Sugimoto K, Tanaka T, Won CW, Yamada M, Zhang T, Akishita M, Arai H. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020 Mar;21(3):300-307.e2. doi: 10.1016/j.jamda.2019.12.012.

[28] Chainy GBN, Sahoo DK. Hormones and oxidative stress: an overview. Free Radic Res 2020;54:1–26. doi: 10.1080/10715762.2019.1702656.

[29] Ghorbanzadeh M, Bakhtiari A, Hajian-Tilaki K, Abbaszadeh-Amirdehi M. Association of multidimensional frailty and dynapenia with fall risk in older adults. BMC Geriatr. 2025 Jul 2;25(1):442. doi: 10.1186/s12877-025-06097-z.

[30] da Costa Pereira JP, Queiroz Júnior JRA, Medeiros LC, Araújo Bezerra GK, Porto IVP, Cabral PC, Luz MCLD, Pinho CPS, Romero RA. Sarcopenia and dynapenia is correlated to worse quality of life perception in middle-aged and older adults with Parkinson's disease. Nutr Neurosci. 2024 Apr;27(4):310-318. doi: 10.1080/1028415X.2023.2190246. [31] Alexandre Tda S, Duarte YA, Santos JL, Wong R, Lebrão ML. Sarcopenia according to the European Working Group on Sarcopenia in Older People (EWGSOP) versus dynapenia as a risk factor for mortality in the elderly. J Nutr Health Aging. 2014;18(8):751-6. doi: 10.1007/s12603-014-0540-2.

[32] de Mello RGB, Dalla Corte RR, Gioscia J, Moriguchi EH. Effects of physical exercise programs on sarcopenia management, dynapenia, and physical performance in the elderly: a systematic review of randomized clinical trials. J Aging Res. 2019;2019:1959486. doi: 10.1155/2019/1959486.

[33] Vincent KR, Braith RW, Feldman RA, Magyari PM, Cutler RB, Persin SA, et al. Resistance exercise and physical performance in adults aged 60 to 83. J Am Geriatr Soc. 2002;50:1100–7. doi: 10.1046/j.1532-5415.2002.50267.x.

[34] Crowley E, Harrison AJ, Lyons M. The impact of resistance training on swimming performance: a systematic review. Sports Med. 2017;47:2285–307. doi: 10.1007/s40279-017-0730-2.

[35] Deutz NE, Bauer JM, Barazzoni R, Biolo G, Boirie Y, Bosy-Westphal A, et al. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clin Nutr. 2014;33:929–36. doi: 10.1016/j.clnu.2014.04.007.

[36] Halfon M, Phan O, Teta D. Vitamin D: a review on its effects on muscle strength, the risk of fall, and frailty. Biomed Res Int. 2015;2015:953241. doi: 10.1155/2015/953241.

[37] Ganesan K, Rahman S, Zito PM. Anabolic steroids. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2023.

[38] Olarescu NC, Gunawardane K, Hansen TK, Møller N, Jørgensen JOL. Normal physiology of growth hormone in adults. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, eds. Endotext. South Dartmouth, MA: MDText.com, Inc.; 2000.

[39] Barbonetti A, D’Andrea S, Francavilla S. Testosterone replacement therapy. Andrology 2020;8:1551–66. doi: 10.1111/andr.12774.

[40] Clark BC, Manini TM. Sarcopenia =/= dynapenia. J Gerontol A Biol Sci Med Sci. 2008 Aug;63(8):829-34. doi: 10.1093/gerona/63.8.829.

[41] Kjøbsted R, Hingst JR, Fentz J, Foretz M, Sanz MN, Pehmøller C, Shum M, Marette A, Mounier R, Treebak JT, Wojtaszewski JFP, Viollet B, Lantier L. AMPK in skeletal muscle function and metabolism. FASEB J. 2018 Apr;32(4):1741-1777. doi: 10.1096/fj.201700442R.

[42] Wong RSY, Cheong SK. Therapeutic potential of mesenchymal stem cells and their derivatives in sarcopenia. Malays J Pathol 2022;44:429– 42.

[43] Maricelli JW, Bishaw YM, Wang B, Du M, Rodgers BD. Systemic SMAD7 gene therapy ıncreases striated muscle mass and enhances exercise capacity in a dose-dependent manner. Hum Gene Ther 2018;29:390–9. doi: 10.1089/hum.2017.158.

[44] An J, Ryu HK, Lyu SJ, Yi HJ, Lee BH. Effects of preoperative telerehabilitation on muscle strength, range of motion, and functional outcomes in candidates for total knee arthroplasty: a single-blind randomized controlled trial. Int J Environ Res Public Health 2021;18:6071. doi: 10.3390/ijerph18116071.

Downloads

  • PDF

Published

2026-02-14

How to Cite

1.
MALON, Paulina, ŚLIWA, Karol, PIEŃKOWSKA, Anita, TROJAŃSKA, Aleksandra, GEWORKIAN, Nel, HARIASZ, Natalia, PIETZ, Martyna and SZYMAŃSKA, Anita. Dynapenia syndrome in geriatrics – clinical characteristics, distinction from sarcopenia, and contemporary therapeutic approaches. Journal of Education, Health and Sport. Online. 14 February 2026. Vol. 88, p. 68065. [Accessed 15 February 2026]. DOI 10.12775/JEHS.2026.88.68065.
  • ISO 690
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 88 (2026)

Section

Health Sciences

License

Copyright (c) 2026 Paulina Malon, Karol Śliwa, Anita Pieńkowska, Aleksandra Trojańska, Nel Geworkian, Natalia Hariasz, Martyna Pietz, Anita Szymańska

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0

Stats

Number of views and downloads: 2
Number of citations: 0

Search

Search

Browse

  • Browse Author Index
  • Issue archive

User

User

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Information

  • For Readers
  • For Authors
  • For Librarians

Newsletter

Subscribe Unsubscribe

Tags

Search using one of provided tags:

dynapenia, muscle aging, functional capacity in older adults, resistance training, supplementation, protein, vitamin D, fall prevention
Up

Akademicka Platforma Czasopism

Najlepsze czasopisma naukowe i akademickie w jednym miejscu

apcz.umk.pl

Partners

  • Akademia Ignatianum w Krakowie
  • Akademickie Towarzystwo Andragogiczne
  • Fundacja Copernicus na rzecz Rozwoju Badań Naukowych
  • Instytut Historii im. Tadeusza Manteuffla Polskiej Akademii Nauk
  • Instytut Kultur Śródziemnomorskich i Orientalnych PAN
  • Instytut Tomistyczny
  • Karmelitański Instytut Duchowości w Krakowie
  • Ministerstwo Kultury i Dziedzictwa Narodowego
  • Państwowa Akademia Nauk Stosowanych w Krośnie
  • Państwowa Akademia Nauk Stosowanych we Włocławku
  • Państwowa Wyższa Szkoła Zawodowa im. Stanisława Pigonia w Krośnie
  • Polska Fundacja Przemysłu Kosmicznego
  • Polskie Towarzystwo Ekonomiczne
  • Polskie Towarzystwo Ludoznawcze
  • Towarzystwo Miłośników Torunia
  • Towarzystwo Naukowe w Toruniu
  • Uniwersytet im. Adama Mickiewicza w Poznaniu
  • Uniwersytet Komisji Edukacji Narodowej w Krakowie
  • Uniwersytet Mikołaja Kopernika
  • Uniwersytet w Białymstoku
  • Uniwersytet Warszawski
  • Wojewódzka Biblioteka Publiczna - Książnica Kopernikańska
  • Wyższe Seminarium Duchowne w Pelplinie / Wydawnictwo Diecezjalne „Bernardinum" w Pelplinie

© 2021- Nicolaus Copernicus University Accessibility statement Shop